stage III lymphoepithelioma of the oropharynx
Showing 1 - 25 of >10,000
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in
Recruiting
- Malignant Neoplasm of Oropharynx Stage III
- +7 more
- Escalated Dose
- Standard Dose
-
Kolkata, West Bengal, IndiaTata Medical Centre
Dec 2, 2021
Head Neck Cancer Trial in France (cisplatin, docetaxel, fluorouracil)
Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)
Recruiting
- Head and Neck Cancer
- biologic sample preservation procedure
- medical chart review
-
Nashville, Tennessee
- +3 more
Oct 28, 2022
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma
Completed
- Stage II Lymphoepithelioma of the Nasopharynx
- +5 more
- docetaxel
- +5 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 10, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Anorexia, Cachexia, Head Neck Cancer Trial in Winston-Salem (megestrol acetate, quality-of-life assessment)
Completed
- Anorexia
- +3 more
- megestrol acetate
- quality-of-life assessment
-
Winston-Salem, North CarolinaComprehensive Cancer Center at Wake Forest University
Sep 7, 2021
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage
Completed
- Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
- +2 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Mar 16, 2021
Oral Cancer, Oropharynx Cancer, Hypopharynx Cancer Trial in Vandoeuvre les Nancy, Villejuif (IMRT 75 Gy, Conventional
Completed
- Oral Cancer
- +2 more
- IMRT 75 Gy
- +2 more
-
Vandoeuvre les Nancy, France
- +1 more
Apr 14, 2020
ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck
Active, not recruiting
- Cancer
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia
Active, not recruiting
- Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
- Nelfinavir (Viracept®) 1250 mg
- FMISO
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 30, 2021
Squamous Cell Carcinoma Trial in Philadelphia (fluorine F18 EF5, immunohistochemistry staining method, biopsy)
Completed
- Squamous Cell Carcinoma
- fluorine F18 EF5
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 23, 2020
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- erlotinib hydrochloride
- +10 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020
Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Oropharynx, Stage I Verrucous
Completed
- Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity
- +18 more
- BRB Lozenge
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)
Completed
- Head and Neck Cancer
- +3 more
- sargramostim
- oral salt and soda mouthwash
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 9, 2021
Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)
Active, not recruiting
- Laryngeal Cancer Stage II
- +3 more
- radiotherapy
- Olaparib
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Sep 27, 2022
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)
Recruiting
- HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
- HB-201 IT
- HB-201 IV
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022
Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)
Active, not recruiting
- Head and Neck Cancer
- carboplatin,
- +4 more
-
Singapore, SingaporeNational Cancer Centre - Singapore
Sep 27, 2022